| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/05/2000 | EP0968168A1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0967997A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
| 01/05/2000 | EP0967977A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
| 01/05/2000 | EP0967976A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 01/05/2000 | EP0967878A1 Targeted cytotoxic cells |
| 01/05/2000 | EP0817779B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/05/2000 | EP0758342B1 New peptide active substance and production thereof |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | EP0427765B1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
| 01/05/2000 | DE19915954A1 Cyclooxygenaseinhibitor Cyclooxygenase |
| 01/05/2000 | CN1240430A Bis(acridinecarboxamide) and Bis(phenazinecarboxamide) as antitumour agents |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240357A Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 01/05/2000 | CN1240348A Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 01/05/2000 | CN1240147A Kunyuan glg oral liquor |
| 01/05/2000 | CN1048015C Bicyclic tetrahydro pyrazolopyridines |
| 01/05/2000 | CN1048014C Substituted pyrroles compound and preparational process, medicinal compositions and use |
| 01/04/2000 | US6011166 Trinuclear cationic platinum complexes having antitumor activity and pharmaceutial compositions containing them |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6011063 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011029 Benzodiazepine compounds |
| 01/04/2000 | US6011009 Method for determining angiogenesis using scatter factor |
| 01/04/2000 | US6011003 Vascular endothelial growth factor (vegf) inhibitors |
| 01/04/2000 | US6010905 Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | CA2029368C Injectable solution and process for preparing same |
| 01/01/2000 | CA2276984A1 Cyclooxygenase inhibitor |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067379A2 Structured antisense nucleic acid molecules |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 12/29/1999 | WO1999067258A1 Arylsulfonanilide phosphates |
| 12/29/1999 | WO1999067252A2 Epothilone derivatives and their synthesis and use |
| 12/29/1999 | WO1999067250A1 Syntheses of a variety of lamellarin compounds and analogues |
| 12/29/1999 | WO1999067249A1 Alkyl ether analogs of chlorins having an n-substituted imide ring |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | WO1999066931A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 12/29/1999 | WO1999066917A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 12/29/1999 | WO1999060133A3 Human nucleic acid methylases |
| 12/29/1999 | WO1999057320B1 Antisense modulation of cd40 expression |
| 12/29/1999 | WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor |
| 12/29/1999 | WO1999055830A3 Process for synthesizing cox-2 inhibitors |
| 12/29/1999 | WO1999055715A3 Polysaccharide-antigen conjugates |
| 12/29/1999 | WO1999055377A3 Polyol-ifn-beta conjugates |
| 12/29/1999 | WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/29/1999 | WO1999049774A3 Methods for the diagnosis and treatment of lung cancer |
| 12/29/1999 | WO1999042564A3 Apoptotic cell-mediated antigen presentation to dendritic cells |
| 12/29/1999 | WO1998055150A8 Txu-7-pap immunotoxin and use thereof |
| 12/29/1999 | EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| 12/29/1999 | EP0967276A2 Anti-tumor agent comprising salmosin |
| 12/29/1999 | EP0966534A1 Compositions and methods for elimination of unwanted cells |
| 12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
| 12/29/1999 | EP0966523A1 Method for the production of selected lymphocytes |
| 12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
| 12/29/1999 | EP0966476A1 Quinazolinone compounds |
| 12/29/1999 | EP0966465A1 Inhibitors of impdh enzyme |
| 12/29/1999 | EP0966456A1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 12/29/1999 | EP0966446A1 Bicyclic inhibitors of protein farnesyl transferase |
| 12/29/1999 | EP0966439A1 Certain cyclic thio substituted acylaminoacid amide derivatives |
| 12/29/1999 | EP0966427A1 Preparation of acid amides and metallisation of compounds |
| 12/29/1999 | EP0966304A1 Site-specific drug delivery |
| 12/29/1999 | EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes |
| 12/29/1999 | EP0966277A1 Use of r-nsaid's for the prevention of alzheimer's disease |
| 12/29/1999 | EP0966266A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 12/29/1999 | EP0966197A1 Plasmin-depletion therapy |
| 12/29/1999 | EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 12/29/1999 | EP0851922B1 Cyclin depenpent kinase binding compounds |
| 12/29/1999 | EP0822993B1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1 |
| 12/29/1999 | EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy |
| 12/29/1999 | EP0751788B1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 12/29/1999 | EP0668781B1 Lymphokine gene therapy of cancer in combination with tumor antigens |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | CN1239964A Tetraphosphonate bicyclic trisanhydrides |
| 12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 12/29/1999 | CN1239950A New derivates from piperidine-keto acid, their preparation and use |
| 12/29/1999 | CN1239949A Novel heterocyclically substituted benzamides and their use in fighting diseases |
| 12/29/1999 | CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs. |
| 12/29/1999 | CN1239892A Use of equilenin as antioxidant |
| 12/29/1999 | CN1239891A Use of 17 '-dihydroequilenin as an antioxidant |
| 12/29/1999 | CN1239890A 17 'alpha'-dihydroequilenin for use as medical antioxidant |
| 12/29/1999 | CN1239673A South-China Osmunda japonica tea and its preparation |
| 12/29/1999 | CN1239659A Cancer treating granule |
| 12/29/1999 | CN1047778C Pyrimido [5,4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them |
| 12/29/1999 | CN1047776C Pharmacologically active pyridine derivatives and process for the preparation thereof |
| 12/29/1999 | CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion |
| 12/29/1999 | CA2335559A1 Arylsulfonanilide phosphates |
| 12/29/1999 | CA2334322A1 Syntheses of a variety of lamellarin compounds and analogues |
| 12/29/1999 | CA2331919A1 Structured antisense nucleic acid molecules |
| 12/29/1999 | CA2331769A1 Prostate cancer-associated genes |